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Diabetes mellitus is a chronic disorder together with other metabolic abnormalities, usually developed 
due to insulin resistance or deficiency as well as increased hepatic glucose output [1]. The prevalence of 
diabetes mellitus among Malaysians adults more than 30 years of age has escalated by more than two 
fold over a 20-year period [2].  
On the other hand, many plants have been used for the treatment of diabetes mellitus in modern 
system of medicine and in other ancient systems of the world. As a result, plants are now-a-days 
regarded as promising and significantly attractive natural sources to enrich the current therapy options 
against diabetes. However, so far, not many active agents have been successfully isolated and 
extensively studied [3]. Hence, we prompted to evaluate the antidiabetic potential of a flavonoid (5,7-
dihydroxy-8-methoxyflavone [4], Figure 1) isolated from the leaves of Tetracera indica Merr., a 
Malaysian medicinal plant which is traditionally used to treat diabetes in Malaysia.  
The study was carried out using Sprague-Dawley rats (diabetic as well as normal) to evaluate 
antidiabetic potential of 5,7-dihydroxy-8-methoxyflavone at three different concentrations, viz. 1 mg/kg 
b.w., 5 mg/kg b.w. and 25 mg/kg b.w. At 5 mg/kg b.w. and 25 mg/kg b.w., it was found to exhibit 
significant anti-hyperglycemic activity in alloxan induced diabetic rats and in normal rats, no 
hypoglycemic activity was observed at all concentrations, when compared with +ve and –ve controlled 
groups. The antidiabetic activity was found to be comparable with glibenclamide (GLBC), a known oral 
hypoglycemic agent (50 mg/kg b.w.) (Table 1). The LD50 of 5,7-dihydroxy-8-methoxyflavone was found to 
be more than 500 mg/kg b.w. and no lethal toxicity was observed within this range. Three weeks later, 
the in-vivo study, histopathology of kidney and pancreas from alloxan-induced rats demonstrated the 
clinical manifestation of diabetic affected kidney and pancreas (Figures 2 & 3). It is concluded that the 
5,7-dihydroxy-8-methoxyflavone from the leaves of T. indica is a safe and promising antidiabetic agent 
that could prove useful in the management of diabetes and might also provide lead for the synthesis of 
a new class of safe antidiabetic drugs.  
Keywords: 5,7-dihydroxy-8-methoxyflavone, Tetracera indica, antidiabetic agent 
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 Fig. 1: Structure of isolated flavonoid (5,7-dihydroxy-8-methoxyflavone) from the leaves of Tetracera indica Merr. 
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Table 1. Effect of different doses of 5,7-dihydroxy-8-methoxyflavone on blood glucose levels (mmoL/L) in normal and diabetic rats at 
different intervals (days). The values represent the standard error of mean (S.E.M.). *indicates a significant change in  
blood glucose level (p<0.005). 
 
 
Fig. 1: Diabetic group of rats treated with high dose of  
Mflavone (25 mg/kg b.w.) showing mild segmental  
mesangial matrix expansion from the glomeruli with partial  
hyalinization of glomerulus (kidney section) 
 
 
Fig. 2: Diabetic group of rats treated with high dose of  
Mflavone (25 mg/kg). After 3 weeks of study, the pancreas  
tissue- the lighter staining tissue within the lobules represent  
the endocrine component of the pancreas, the pancreatic Islets  
of Langerhans and restoration of normal cellular population  
size of islets of Langerhans and less damage to islets  
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Currently, phytochemical databases that store information on ethnobotanical plants, compounds and its 
uses in Asia are limited and do not comprehensively cover the extent of digitally available information 
for specific species. Asia and its rich ethno botanical medicine and associated heritage encompass a 
multitude of cultures, ranging from Chinese and Ayurvedic to Indo-Malay traditional medicine. Although 
there are an abundance of data and information, they are scattered with only a few specific databases 
that cater for ethnobiology and vast information available in textual format due to its historical nature. 
Therefore, an establishment of a comprehensive ethnobotanical database will facilitate information 
gathering and preserve the biocultural knowledge that is facing extinction due to habitat loss and 
modern development. This database Phyknome will enable researchers and public to seek and identify 
ethnobotanical information based on a species scientific name, descriptions and phytochemical 
information. Up until now, Phyknome hosts more than 22,000 plant species with 14 Divisions, 18 Class, 
745 Families and more than 28,000 Genus. Plant scientific names were cross-checked with International 
Plant Index (IPNI) for verification. It is constructed using a digitization pipeline that allow high 
throughput digitization of archival data, an automated data miner to mine for pharmaceutical 
compounds information and an online database to integrated these information. Active compounds 
structure and publication information is mined from PubChem and PubMed database respectively. The 
pipeline is integrated with android smartphone application that can be used to report occurrences and 
obtain ethnobotanical data on-the-go. The main functions include an automated taxonomy, search 
query based on chemical compound, geolocation and bibliography. We believe that Phyknome will 
contribute to the digital knowledge ecosystem to elevate access and provide tools for ethnobotanical 
research and contributes to the management, assessment and stewardship of biodiversity. The database 
is available at http://mapping.fbb.utm.my/phyknome/.  
 
Keywords: Ethnobotany, phytochemicals, databases 
 
 
 
 
 
 
52 
 
 
 
 
 
 
 
Fig. 1: Phyknome homepage; contain  
featured researchers, featured plant species,  
plant species counter, login page  
 
Fig. 2: Example species page; shows accepted  
names (based on International Plant Index  
(IPNI)), synonym(s), vernacular name (s), Chinese  
name, taxonomic classifications  
 
 
 
 
Fig. 3: Example data information; plant  
usage, parts used, precaution, other uses,  
active compound, chemical structure from  
PubChem, retrieved PubMed publications,  
other references resource  
 
Fig. 4: Geographical information; based on GPS  
coordinate and retrieved from GBIF API species  
distribution  
 
